The endogenous Apc2 promoter drives expression of full-length, wild-type Apc2 which is tagged at the C-terminal end with a mitochondrial targeting sequence (Tag:Mito(actA)) and at the N-terminal end with EGFP.
The cuticle defects of embryos derived from Apc2g10 ApcQ8 males crossed to females containing double homozygous germline clones are rescued by expression of Apc2T:Avic\GFP-EGFP,T:Zzzz\Mito-actA. The embryonic lethality is partially rescued (19% lethality is seen).
Apc2EGFP,Tag:Mito(actA) partially rescues Apc2g10
Apc2T:Avic\GFP-EGFP,T:Zzzz\Mito-actA rescues the cuticle defects of embryos lacking both maternal and zygotic Apc2[+] function (homozygous Apc2g10 embryos derived from Apc2g10 females). The embryonic lethality of these Apc2 mutants is largely rescued (14% embryonic lethality is seen), and viable adults are obtained.